Early perimenopause happens when the hormonal shift toward menopause begins well before the typical age range, and its causes span a surprisingly wide spectrum: inherited genetic variation, cigarette smoking, chemical exposures, certain medical treatments, autoimmune conditions, and reproductive history all play documented roles. Most women enter perimenopause in their mid-to-late forties, with the final menstrual period arriving around age 51 on average. When that transition kicks off years ahead of schedule, it is rarely one factor acting alone but rather several interacting at once, and some of them are modifiable.
What Counts as “Early” and Why the Distinction Matters
Clinicians generally separate early menopause (final period before age 45) from premature ovarian insufficiency, where ovarian function declines before age 40. Premature ovarian insufficiency affects roughly one to three percent of postmenopausal women and is tied to higher rates of cardiovascular disease, diabetes, osteoporosis, fractures, cognitive decline, and depression. Early menopause carries most of these same elevated risks at a similar magnitude.1PubMed Central. Is Early Menopause a Different Entity From Premature Ovarian Insufficiency? Because perimenopause is the transitional phase leading up to the final period, early perimenopause simply means this transition is beginning sooner than expected. A woman whose perimenopause starts at 38, for example, may not reach full menopause until her early-to-mid forties, but those years of hormonal fluctuation still come with symptoms and health consequences that deserve attention.
A 34-year prospective study following 390 women found that those with early menopause had roughly 83 percent higher odds of osteoporosis by age 77, 68 percent higher odds of fragility fractures, and 59 percent higher mortality risk compared to women who reached menopause at a typical age.2PubMed. Early menopause and risk of osteoporosis, fracture and mortality: a 34-year prospective observational study in 390 women The American Heart Association has also flagged the menopause transition as a period of unfavorable changes in body composition, lipid levels, and vascular health that raise cardiovascular risk afterward.3PubMed Central. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention The earlier those changes begin, the longer a woman’s body goes without the cardiovascular protection that estrogen provides, and bone loss accelerates specifically during late perimenopause and early menopause.4PubMed. Trabecular bone score and bone remodelling markers identify perimenopausal women at high risk of bone loss
The Genetic Component Is Substantial
If your mother or older sister went through menopause early, you are statistically more likely to as well. A study of mothers and daughters estimated that the heritability of menopausal age is about 44 percent, meaning nearly half the variation in when women reach menopause can be attributed to inherited factors.5PubMed. Heritability of menopausal age in mothers and daughters That is a large genetic contribution, comparable to the heritability of traits like height or blood pressure, and it means family history is one of the most useful predictors available.
Genome-wide studies in large cohorts of Northern European women have identified hundreds of genetic variants linked to the timing of menopause. These variants cluster in genes involved in immune function, mitochondrial activity, and DNA repair and maintenance.6PubMed Central. Shared Genetics Between Age at Menopause, Early Menopause, POI and Other Traits The DNA-repair connection makes intuitive sense: oocytes (egg cells) are among the longest-lived cells in the body, sitting in the ovaries for decades. If the molecular machinery that keeps their DNA intact is slightly less efficient due to genetic variation, the pool of viable eggs shrinks faster, and ovarian function winds down sooner. No single gene is responsible, though. The picture is one of many small genetic nudges, each shifting the timeline by a small amount, adding up to a meaningful difference when enough of them point in the same direction.
That said, 44 percent heritability also means the majority of the variation comes from non-genetic factors, which is good news because many of those are at least partially within your control.
Smoking Is the Most Consistent Lifestyle Risk Factor
Of all the modifiable exposures linked to earlier menopause, smoking stands out as the most well-documented. The relationship has held up across decades of studies and multiple populations. Women who smoke tend to reach menopause one to two years earlier than non-smokers, and the effect appears to be dose-dependent: the more cigarettes per day and the more years smoked, the larger the shift. The mechanism involves direct toxicity to the ovarian follicles, with tobacco chemicals accelerating the rate at which the egg supply is depleted. Compounds in cigarette smoke also interfere with estrogen metabolism, effectively lowering the circulating estrogen available to support normal ovarian cycling.
Quitting does reduce the risk, though research suggests the benefit depends on when you quit. Former smokers who stopped well before perimenopause have menopausal timing closer to that of never-smokers, while those who smoked into their forties tend to still experience earlier onset. If you currently smoke and are in your thirties or early forties, stopping now is one of the most concrete things you can do to avoid shifting your menopausal timeline forward.
Environmental Chemicals and the Ovary
Beyond cigarette smoke, a growing body of evidence points to environmental contaminants as players in ovarian aging. Two chemical classes have attracted particular attention: PFAS (per- and polyfluoroalkyl substances, the so-called “forever chemicals”) and phthalates.
In a longitudinal study tracking women through the menopause transition, those with the highest blood levels of certain PFAS compounds reached natural menopause earlier than women with the lowest levels. Women in the top third for PFOS concentrations had about a 26 to 27 percent higher rate of reaching menopause at any given age, and PFOA showed a 31 percent higher rate.7The Journal of Clinical Endocrinology & Metabolism. Associations of Perfluoroalkyl Substances with Incident Natural Menopause: The Study of Women’s Health Across the Nation These are not enormous effect sizes individually, but PFAS exposure is nearly universal in industrialized countries: the chemicals turn up in nonstick cookware, water-resistant clothing, food packaging, and contaminated drinking water.
Phthalates, found in plastics, personal care products, and food packaging, have shown even more striking associations. An analysis of data from the U.S. National Health and Nutrition Examination Survey found that women in the highest ten percent of urinary concentrations of a common phthalate metabolite (DEHP) experienced menopause roughly three to nearly four years earlier than women with lower levels.8PubMed Central. The Effects of Environmental Contaminant Exposure on Reproductive Aging and the Menopause Transition That is a substantial gap, comparable to the shift seen with heavy smoking. The difficulty is that reducing phthalate exposure is harder than it sounds, since these chemicals are embedded throughout everyday consumer products. Choosing fragrance-free personal care items, avoiding microwaving food in plastic containers, and filtering tap water are practical but partial steps.
Medical Treatments That Push the Timeline Forward
Certain medical interventions can damage the ovaries directly, sometimes triggering early perimenopause as a side effect. Chemotherapy and pelvic radiation are the most well-known culprits. Chemotherapy drugs accelerate the death of ovarian follicles and damage the supporting ovarian tissue through multiple molecular pathways. Radiation, meanwhile, harms oocytes through oxidative stress.9PubMed Central. Molecular Mechanism and Prevention Strategy of Chemotherapy- and Radiotherapy-Induced Ovarian Damage The impact depends on the type of drug, the dose, and the woman’s age at treatment. Younger women have a larger ovarian reserve to begin with, so they may tolerate treatment with less immediate damage, but they can still face earlier perimenopause years later. Fertility preservation options like egg or embryo freezing are now routinely discussed before cancer treatment for exactly this reason.
Hysterectomy is another procedure that deserves mention, even when the ovaries are left in place. The prevailing explanation is that removing the uterus disrupts some of the blood supply to the ovaries, which could lead to reduced hormone production and earlier ovarian decline.10PubMed Central. Effect of Hysterectomy With Ovarian Preservation on Ovarian Function The effect is more pronounced when one ovary is removed along with the uterus. A prospective cohort study found that women who had a hysterectomy with removal of one ovary reached menopause about 4.4 years earlier than those who kept both ovaries during the same surgery.11PubMed. The association of hysterectomy and menopause: a prospective cohort study This is a meaningful shift, and it is worth factoring into the conversation if hysterectomy is on the table for conditions like fibroids or endometriosis.
Autoimmune Disease and Thyroid Conditions
Autoimmune conditions, particularly thyroid autoimmunity, have an underappreciated relationship with ovarian function. In a large health-insurance database study, women with Hashimoto’s disease (the most common cause of underactive thyroid) had an 89 percent higher risk of amenorrhea and a 2.4-fold higher risk of ovarian-failure-related infertility compared to women without the condition. Women with Graves’ disease (overactive thyroid) showed a 68 percent higher risk of amenorrhea.12Oxford Academic (Human Reproduction). Thyroid autoimmunity is associated with higher risk of premature ovarian insufficiency-a nationwide Health Insurance Research Database study
The likely connection is that the same misdirected immune activity attacking the thyroid gland can also target ovarian tissue. Autoimmune conditions tend to cluster, so a woman with one autoimmune diagnosis is more likely to develop another. If you have been diagnosed with thyroid autoimmunity, awareness of this link means you can keep an eye out for symptoms of declining ovarian function, like cycle changes or hot flashes, and bring them up with your doctor earlier than you might otherwise think to.
Reproductive History Plays a Role Too
When you first got your period and whether you have been pregnant both appear to influence when perimenopause arrives. A large Australian study found that women with early menarche (first period before age 12) had nearly double the risk of premature menopause (before age 40) and about a 31 percent higher risk of early menopause (before age 45) compared to women whose first period came at age 13.13Human Reproduction. Early menarche, nulliparity and the risk for premature and early natural menopause The logic may be that an earlier start to cycling means the ovarian reserve begins its decline sooner, though the relationship is not universally replicated across all populations.14Maturitas. Factors associated with early menopause
Nulliparity, or never having been pregnant, is also associated with earlier menopause. Pregnancy suppresses ovulation for nine months, and breastfeeding extends that suppression further, essentially giving the ovarian reserve a break. Women who go through multiple pregnancies accumulate more months of suppressed cycling over a lifetime, which may help preserve their egg supply slightly longer.
As for oral contraceptives, which also suppress ovulation, the picture is less clear-cut. A study in the DOM cohort found that long-term use of older, high-dose oral contraceptives was associated with reaching menopause about 1.2 months earlier per year of use. However, lower-dose formulations, which are what most women use today, showed no such effect.15Oxford Academic (Human Reproduction). Oral contraceptive use in relation to age at menopause in the DOM cohort So if you are taking a modern contraceptive pill, this is probably not something to worry about.
What You Eat May Matter, but the Evidence Is Modest
Diet is one of those areas where people want clear guidance but the science delivers mixed signals. A systematic review and meta-analysis of dietary factors found that higher intake of green and yellow vegetables was associated with slightly earlier menopause onset, while higher intake of certain dairy products (particularly low-fat and skimmed milk) and low alcohol intake were associated with a later onset. A vegetarian diet showed a possible link to earlier menopause. No consistent association emerged for macronutrient or micronutrient intake, and no other dietary pattern showed a reliable effect.16Maturitas. Dietary factors and onset of natural menopause: A systematic review and meta-analysis
The vegetable finding is a bit counterintuitive and deserves context. It does not mean vegetables are bad for your ovaries. The association may reflect other aspects of a vegetarian or heavily plant-based diet, such as lower body weight (lower BMI is itself associated with earlier menopause, since fat tissue produces estrogen) or phytoestrogen intake. The effect sizes are small, and no dietary change has anywhere near the impact of quitting smoking or avoiding major chemical exposures.
Stress, Adverse Life Events, and Biological Aging
Chronic stress has long been suspected of contributing to earlier reproductive aging, and recent research on epigenetics is starting to fill in the mechanism. A study comparing women with premature ovarian insufficiency to controls found that higher scores on a negative life events scale were significantly associated with accelerated DNA methylation aging, a marker of how quickly cells are aging at the molecular level. Women with premature ovarian insufficiency showed specific epigenetic changes and signs of accelerated biological aging in their blood cells.17PubMed. Association between adverse life events, DNA methylation and risk of premature ovarian insufficiency
Separately, researchers have found that younger women (under 38) with poor ovarian response during fertility treatment showed statistically significant epigenetic age acceleration in their white blood cells, meaning their cells looked biologically older than their chronological age would predict.18Human Reproduction. Young women with poor ovarian response exhibit epigenetic age acceleration based on evaluation of white blood cells using a DNA methylation-derived age prediction model This does not prove that stress directly causes early ovarian decline, but it suggests a plausible pathway: adverse experiences accelerate biological aging broadly, and the ovary, being one of the most age-sensitive organs in the body, may be particularly vulnerable.
Racial and Ethnic Disparities
Menopause timing is not uniform across populations, and untangling biology from social determinants of health is tricky. A recent analysis using a large U.S. dataset found that Asian and Pacific Islander women and Indigenous women experienced significantly earlier menopause onset compared to white women, even after adjusting for neighborhood deprivation, smoking, and alcohol use. The gap between Black and white women, which appeared in unadjusted data, shrank after accounting for socioeconomic and behavioral factors and did not reappear after further refinements to exclude surgical menopause.19medRxiv. Heterogeneity across race and ethnicity for menopause onset
This is a reminder that when we talk about causes of early perimenopause, some of the variation across groups may be downstream of structural inequalities: differences in exposure to environmental toxicants, differences in access to healthcare, chronic stress from discrimination, and dietary patterns shaped by economic constraints. Genetics plays a role, but so does lived experience, and the two are often hard to separate in observational data.
Can You Predict When Perimenopause Will Start?
Anti-Müllerian hormone (AMH) is a blood marker that reflects the size of the remaining ovarian reserve, and it has become the most useful single test for estimating how far off menopause might be. In one study, AMH was a stronger predictor of time to menopause than either FSH or inhibin B, the two hormones traditionally used. Among women aged 45 to 48 with very low AMH levels (below 0.20 ng/ml), the median time to menopause was about six years. In younger women aged 35 to 39 with the same low levels, it was about ten years. Women of any age with higher AMH levels (above 1.50 ng/ml) had considerably longer estimated timelines.20PubMed Central. Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women
An individual patient data meta-analysis confirmed that AMH dramatically improves the ability to predict early menopause specifically: a model using age alone had a predictive accuracy of only about 52 percent for menopause at or before age 45, essentially a coin flip. Adding AMH pushed that to around 80 percent, with the effect strongest in women aged 31 to 40.21The Journal of Clinical Endocrinology & Metabolism. Does AMH Relate to Timing of Menopause? Results of an Individual Patient Data Meta-Analysis Tracking AMH over time may be even more informative than a single measurement, since the rate of decline carries additional predictive power.22Human Reproduction Update. Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review
AMH testing is not yet routine in primary care, but it is increasingly available through reproductive endocrinologists and some direct-to-consumer testing services. If you have risk factors for early menopause, particularly a strong family history, autoimmune thyroid disease, or a history of cancer treatment, asking about AMH testing in your mid-thirties could give you useful information for planning, whether that involves fertility decisions, bone-health monitoring, or early conversations about hormone therapy.
Why Humans Have Menopause at All
Most mammals remain fertile until near the end of their lives. The fact that human women routinely live decades past their last menstrual period is genuinely unusual, shared only with a handful of whale species. The most prominent evolutionary explanation is the “grandmother hypothesis,” which proposes that women who survived well past menopause were able to help feed and care for their grandchildren, allowing their daughters to have more children more quickly.23PubMed Central. Grandmothering, menopause, and the evolution of human life histories Over many generations, genes favoring post-reproductive vigor would have spread through the population.24PubMed Central. The grandmother effect: implications for studies on aging and cognition
This evolutionary framing adds an interesting layer to the question of early perimenopause. The timing of menopause appears to be under genuine selective pressure, not just a byproduct of aging. That helps explain why so many genetic variants are involved and why the heritability is so high: natural selection has been shaping this trait for a long time, and modern environmental exposures like cigarette smoke and industrial chemicals are essentially disrupting a finely tuned biological clock that evolution spent thousands of generations calibrating.